P.A.W. Capital’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $9.38M | Sell |
64,575
-18,720
| -22% | -$2.59M | 2.8% | 7 |
|
|
2026
Q2 | $10.7M | Buy |
83,295
+57,630
| +225% | +$6.75M | 2.82% | 6 |
|
|
2026
Q1 | $3.07M | Buy |
+25,665
| New | +$2.96M | 2.45% | 13 |
|
|
2022
Q4 | – | Sell |
-10,000
| Closed | -$861K | – | 42 |
|
|
2022
Q3 | $861K | Hold |
10,000
| – | – | 1.29% | 19 |
|
|
2022
Q2 | $912K | Sell |
10,000
-1,500
| -13% | -$133K | 1.32% | 19 |
|
|
2022
Q1 | $944K | Hold |
11,500
| – | – | 0.99% | 32 |
|
|
2021
Q4 | $881K | Sell |
11,500
-500
| -4% | -$39.8K | 0.81% | 37 |
|
|
2021
Q3 | $901K | Hold |
12,000
| – | – | 0.8% | 34 |
|
|
2021
Q2 | $933K | Buy |
12,000
+996
| +9% | +$74.1K | 0.78% | 33 |
|
|
2021
Q1 | $809K | Buy |
11,004
+1,572
| +17% | +$116K | 0.71% | 39 |
|
|
2020
Q4 | $736K | Buy |
9,432
+1,048
| +13% | +$80.2K | 0.65% | 40 |
|
|
2020
Q3 | $664K | Sell |
8,384
-524
| -6% | -$41K | 0.72% | 33 |
|
|
2020
Q2 | $657K | Buy |
8,908
+524
| +6% | +$39.4K | 0.74% | 33 |
|
|
2020
Q1 | $616K | Hold |
8,384
| – | – | 0.83% | 33 |
|
|
2019
Q4 | $728K | Hold |
8,384
| – | – | 0.78% | 33 |
|
|
2019
Q3 | $673K | Sell |
8,384
-524
| -6% | -$42K | 0.84% | 39 |
|
|
2019
Q2 | $713K | Sell |
8,908
-524
| -6% | -$40.1K | 0.77% | 34 |
|
|
2019
Q1 | $749K | Hold |
9,432
| – | – | 0.74% | 30 |
|
|
2018
Q4 | $688K | Sell |
9,432
-1,048
| -10% | -$74K | 0.86% | 30 |
|
|
2018
Q3 | $709K | Sell |
10,480
-1,048
| -9% | -$66.8K | 0.75% | 39 |
|
|
2018
Q2 | $668K | Sell |
11,528
-1,048
| -8% | -$59.1K | 0.67% | 39 |
|
|
2018
Q1 | $654K | Hold |
12,576
| – | – | 0.79% | 39 |
|
|
2017
Q4 | $675K | Buy |
12,576
+1,048
| +9% | +$58.1K | 0.85% | 49 |
|
|
2017
Q3 | $704K | Hold |
11,528
| – | – | 0.74% | 59 |
|
|
2017
Q2 | $705K | Hold |
11,528
| – | – | 0.71% | 56 |
|
|
2017
Q1 | $699K | Hold |
11,528
| – | – | 0.71% | 57 |
|
|
2016
Q4 | $648K | Hold |
11,528
| – | – | 0.73% | 54 |
|
|
2016
Q3 | $687K | Hold |
11,528
| – | – | 0.74% | 44 |
|
|
2016
Q2 | $634K | Hold |
11,528
| – | – | 0.73% | 51 |
|
|
2016
Q1 | $582K | Hold |
11,528
| – | – | 0.65% | 57 |
|
|
2015
Q4 | $581K | Hold |
11,528
| – | – | 0.66% | 58 |
|
|
2015
Q3 | $543K | Hold |
11,528
| – | – | 0.62% | 57 |
|
|
2015
Q2 | $626K | Hold |
11,528
| – | – | 0.63% | 57 |
|
|
2015
Q1 | $632K | Sell |
11,528
-210
| -2% | -$11.9K | 0.62% | 59 |
|
|
2014
Q4 | $636K | Hold |
11,738
| – | – | 0.67% | 54 |
|
|
2014
Q3 | $664K | Sell |
11,738
-2,934
| -20% | -$165K | 0.62% | 56 |
|
|
2014
Q2 | $810K | Hold |
14,672
| – | – | 0.81% | 41 |
|
|
2014
Q1 | $795K | Hold |
14,672
| – | – | 0.78% | 36 |
|
|
2013
Q4 | $701K | Hold |
14,672
| – | – | 0.62% | 44 |
|
|
2013
Q3 | $667K | Buy |
14,672
+1,048
| +8% | +$47.8K | 0.56% | 43 |
|
|
2013
Q2 | $604K | Buy |
+13,624
| New | +$608K | 0.51% | 47 |
|
Other funds holding MRK
P.A.W. Capital's MRK Position: Q3 2026 in Review
P.A.W. Capital reduced its Merck (MRK) stake by 22% in Q3 2026, selling an estimated $2.59M and leaving 64,575 shares worth $9.38M. The position accounts for 2.8% of the portfolio, ranked #7.
P.A.W. Capital first reported a position in MRK in Q2 2013 and has held it in 41 quarters since. The position peaked at $10.7M in Q2 2026. 3,979 funds tracked by Wall St. Rank hold MRK as of Q3 2026.
- P.A.W. Capital held 64,575 shares of Merck worth $9.38M as of Q3 2026.
- P.A.W. Capital sold 18,720 Merck shares in Q3 2026, an estimated $2.59M.
- Merck made up 2.8% of P.A.W. Capital's portfolio in Q3 2026, its #7 holding.
- P.A.W. Capital first reported a position in Merck in Q2 2013 and has held it in 41 quarters since.
- P.A.W. Capital's Merck position peaked at $10.7M in Q2 2026.
- 3,979 funds tracked by Wall St. Rank held Merck as of Q3 2026.
Based on P.A.W. Capital's 13F filing for Q3 2026, filed 16 Nov 2026.